Ettinghausen, S E <br/><br/>
Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.  [electronic resource] 

 -  Blood  Jun 1987 
 - 1654-60 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Cells--drug effects<br/>Combined Modality Therapy<br/>Female<br/>Hematopoiesis--drug effects<br/>Hemoglobins--analysis<br/>Humans<br/>Immunotherapy<br/>Interleukin-2--therapeutic use<br/>Killer Cells, Natural--immunology<br/>Lymphokines--pharmacology<br/>Male<br/>Middle Aged<br/>Neoplasms--blood<br/>Recombinant Proteins--therapeutic use